Physician profile
Laura E Ballard
NPI 1295073344
$243.77
in general payments reported to CMS, 2019-2025
8 companies · $73.46 in 2025
The $73.46 reported for 2025 was less than what a typical Nurse Practitioner provider received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $51.49 · 2023: $65.62 · 2024: $53.20 · 2025: $73.46.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $192.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $192.28 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Smith+Nephew, INC. | $69.59 | 2022-2025 | Grafix Pl, Acufex Meniscal Root Repair, Stravix Pl |
| Heron Therapeutics, INC. | $51.28 | 2022-2025 | Zynrelef |
| Avanos Medical | $33.02 | 2023 | On-Q* Pump and Accessories |
| Biowound Solutions, INC. | $24.22 | 2025 | Bio-Connekt |
| Convatec INC. | $18.54 | 2024 | |
| Kowa Pharmaceuticals America, INC. | $16.65 | 2022 | |
| Organogenesis INC. | $16.30 | 2025 | Affinity |
| Pacira Pharmaceuticals Incorporated | $14.17 | 2023 | Iovera, Exparel, Zilretta |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Laura Ballard listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.